The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features

[1]  N. Agarwal,et al.  Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far from the Tree , 2017, Clinical Cancer Research.

[2]  G. Stein,et al.  The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer , 2017, Epigenomics.

[3]  Xueming Li,et al.  Mechanism of chromatin remodelling revealed by the Snf2-nucleosome structure , 2017, Nature.

[4]  Y. Oda,et al.  Oncogenic roles of SMARCB1/INI1 and its deficient tumors , 2017, Cancer science.

[5]  A. Warth,et al.  SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. , 2017, Annals of diagnostic pathology.

[6]  L. Egevad,et al.  Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma: Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency , 2017, The American journal of surgical pathology.

[7]  D. Reisman,et al.  Mechanism of BRG1 silencing in primary cancers , 2016, OncoTarget.

[8]  K. Kuroiwa,et al.  Epithelial to Mesenchymal Transition in Clear Cell Renal Cell Carcinoma with Rhabdoid Features , 2016, Pathobiology.

[9]  B. Rini,et al.  Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma , 2016, International Urology and Nephrology.

[10]  K. Kuroiwa,et al.  Renal cell carcinoma with rhabdoid-like features lack intracytoplasmic inclusion bodies and show aggressive behavior , 2016, Virchows Archiv.

[11]  A. Belldegrun,et al.  Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma , 2016, Proceedings of the National Academy of Sciences.

[12]  M. Beckmann,et al.  Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. , 2015, Annals of diagnostic pathology.

[13]  Liqun Zhou,et al.  Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients. , 2015, Annals of diagnostic pathology.

[14]  E. Collisson,et al.  Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation , 2015, Genes & development.

[15]  A. Hartmann,et al.  SMARCB1 (INI1)-negative Rhabdoid Carcinomas of the Gastrointestinal Tract: Clinicopathologic and Molecular Study of a Highly Aggressive Variant With Literature Review , 2014, The American journal of surgical pathology.

[16]  M. Kandil,et al.  Renal Cell Carcinoma With Rhabdoid and Sarcomatoid Features Presented as a Metastatic Thigh Mass With an Unusual Immunohistochemical Profile , 2014, Rare tumors.

[17]  J. Cheville,et al.  The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters , 2013, The American journal of surgical pathology.

[18]  J. Yokota,et al.  A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. , 2013, Cancer research.

[19]  T. Owen-Hughes,et al.  Mechanisms and Functions of ATP-Dependent Chromatin-Remodeling Enzymes , 2013, Cell.

[20]  G. Crabtree,et al.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy , 2013, Nature Genetics.

[21]  S. Ishikawa,et al.  Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features , 2013, Cancer science.

[22]  K. Harada,et al.  Expression of epithelial–mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy , 2012, BJU international.

[23]  Dereje D. Jima,et al.  The genetic landscape of mutations in Burkitt lymphoma , 2012, Nature Genetics.

[24]  Matthew J. Betts,et al.  Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.

[25]  Jill P. Mesirov,et al.  MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS , 2012, Nature.

[26]  R. Hruban,et al.  Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. , 2012, Human pathology.

[27]  Joanna L. Conant,et al.  Sarcomatoid renal cell carcinoma is an example of epithelial–mesenchymal transition , 2011, Journal of Clinical Pathology.

[28]  A. Postigo,et al.  ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1 , 2010, Oncogene.

[29]  E. Nogales,et al.  Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription. , 2010, Progress in biophysics and molecular biology.

[30]  E. Ballestar,et al.  Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells. , 2005, Human molecular genetics.

[31]  J. Cheville,et al.  Sarcomatoid Renal Cell Carcinoma: An Examination of Underlying Histologic Subtype and an Analysis of Associations With Patient Outcome , 2004, The American journal of surgical pathology.

[32]  Stuart H. Orkin,et al.  The SWI/SNF complex — chromatin and cancer , 2004, Nature Reviews Cancer.

[33]  Weidong Wang,et al.  Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. , 2003, Cancer research.

[34]  D. Teng,et al.  BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. , 2000, Cancer research.

[35]  J. Pfeifer,et al.  Renal cell carcinoma with rhabdoid features. , 2000, The American journal of surgical pathology.

[36]  Y. Iwamoto,et al.  SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma , 2018, The American journal of surgical pathology.